Martingale Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-69,926
| Closed | -$1.1M | – | 867 |
|
|
2024
Q1 | $1.1M | Sell |
69,926
-600
| -0.9% | -$9.44K | 0.02% | 449 |
|
|
2023
Q4 | $1.14M | Buy |
70,526
+5
| +0% | +$81 | 0.02% | 426 |
|
|
2023
Q3 | $897K | Sell |
70,521
-3,164
| -4% | -$40.2K | 0.02% | 466 |
|
|
2023
Q2 | $1.04M | Buy |
73,685
+16,639
| +29% | +$234K | 0.02% | 438 |
|
|
2023
Q1 | $881K | Buy |
57,046
+28
| +0% | +$433 | 0.02% | 476 |
|
|
2022
Q4 | $935K | Buy |
57,018
+28,059
| +97% | +$460K | 0.02% | 477 |
|
|
2022
Q3 | $536K | Sell |
28,959
-10,209
| -26% | -$189K | 0.01% | 607 |
|
|
2022
Q2 | $516K | Sell |
39,168
-11,892
| -23% | -$157K | 0.01% | 637 |
|
|
2022
Q1 | $474K | Buy |
51,060
+15,404
| +43% | +$143K | 0.01% | 647 |
|
|
2021
Q4 | $349K | Buy |
35,656
+29,749
| +504% | +$291K | ﹤0.01% | 713 |
|
|
2021
Q3 | $201K | Buy |
5,907
+3
| +0.1% | +$102 | ﹤0.01% | 825 |
|
|
2021
Q2 | $217K | Buy |
+5,904
| New | +$217K | ﹤0.01% | 787 |
|